These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6744774)

  • 1. Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol.
    Dujovne CA; DeCoursey S; Krehbiel P; Jackson B; Chernoff S
    Clin Pharmacol Ther; 1984 Aug; 36(2):157-62. PubMed ID: 6744774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M; Hurt E; Silva H; Urbina-Quintana A; Hernández-Pieretti O; Feldstein E; Camejo G
    Am J Med; 1986 Feb; 80(2A):109-13. PubMed ID: 3080882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood lipid effects of antihypertensive therapy: a double-blind comparison of the effects of methyldopa and propranolol.
    Leon AS; Agre J; McNally C; Bell C; Neibling M; Grimm R; Hunninghake DB
    J Clin Pharmacol; 1984; 24(5-6):209-17. PubMed ID: 6747018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diuretic and propranolol on plasma lipoprotein lipids.
    Bauer JH; Brooks CS; Weinstein I; Wilcox HH; Heimberg M; Burch RN; Barkley R
    Clin Pharmacol Ther; 1981 Jul; 30(1):35-43. PubMed ID: 7237896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E; Velasco M; Silva H; Camejo G
    Biomed Biochim Acta; 1987; 46(1):111-8. PubMed ID: 3107546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum lipid levels during antihypertensive therapy.
    Med J Aust; 1984 Apr; 140(9):522-4. PubMed ID: 6369095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and dynamic responses to single and repeated doses of methyldopa and propranolol during dynamic physical activity.
    Rosenthal L; Affrime MB; Lowenthal DT; Falkner B; Saris S; Gould AB
    Clin Pharmacol Ther; 1982 Dec; 32(6):701-10. PubMed ID: 6754210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.
    Lowenstein J; Neusy AJ
    Am J Med; 1984 Feb; 76(2A):79-84. PubMed ID: 6702864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    Br J Clin Pharmacol; 1982; 13(Suppl 2):441S-444S. PubMed ID: 7104158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the combination of nicotinic acid and propranolol in very low doses on blood lipids in man.
    Avogaro P; Capri C; Cazzolato G; Pais M; Trabuio GF
    Atherosclerosis; 1974; 20(2):395-400. PubMed ID: 4369975
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of propranolol and prazosin on blood lipids. The Oslo Study.
    Leren P; Foss PO; Helgeland A; Hjermann I; Holme I; Lund-Larsen PG
    Lancet; 1980 Jul; 2(8184):4-6. PubMed ID: 6104255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of propranolol therapy and proteinuria in the etiology of post renal transplantation hyperlipidemia.
    Jackson JM; Lee HA
    Clin Nephrol; 1982 Aug; 18(2):95-100. PubMed ID: 6754194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the lipoprotein profile during antihypertensive therapy.
    Helgeland A; Leren P; Kjeldsen S; Eide I; Foss OP
    Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():75-7. PubMed ID: 6711333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyldopa and propranolol or practolol in moderate hypertension.
    Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
    Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized stress and hypertension: comparison of effect of propranolol and methyldopa.
    Dunn FG; Melville DI; Jones JV; Lorimer AR; Lawrie TD
    Br J Clin Pharmacol; 1978 Mar; 5(3):223-6. PubMed ID: 656266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia.
    Rogers WA; Donovan EF; Kociba GJ
    J Am Vet Med Assoc; 1975 Jun; 166(11):1092-1100. PubMed ID: 166057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.